New test of PML risk
A blood test of people who are JCV positive may be able to identify those with lower risk of PML who might be able to stay on treatment with natalizumab (Tysabri). A larger trial involving 342 people is underway. From ECTRIMS.
MedPage Today
Medscape (requires free registration)
Natalizumab (Tysabri) - A to Z of MS
PML (Progressive multifocal leukoencephalopathy) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news